Top 16 Biomea Fusion investors
The most complete profiles first. Showing 16 of 16.
Joshua KennedyVerified
Hedge Fund, Venture Capital, Investor · United States
Series BHealth CareGeneticsInvestment ManagementLife SciencePortfolio: AveXis, Frequency Therapeutics, Roivant Sciences, Magnolia Medical Technologies and 28 more
Verified email available
Stephanie A. SirotaVerified
Hedge Fund, Venture Capital, Investor · United States
Series BHealth CareGeneticsEnterprise SoftwareInvestment ManagementPortfolio: AveXis, Frequency Therapeutics, Roivant Sciences, Magnolia Medical Technologies and 28 more
Verified email available
Sunny ReddyVerified
Venture Capital, Private Equity Firm, Investor · United States
SeedHealth CareWomen FoundedLife ScienceBiotechnologyPortfolio: Zeltiq Aesthetics, Dermira, Spruce Biosciences, Syros Pharmaceuticals and 56 more
Verified email available
Aftab KheraniVerified
Venture Capital, Private Equity Firm · United States
Health CareWomen FoundedLife ScienceBiotechnologyPortfolio: Zeltiq Aesthetics, Dermira, Spruce Biosciences, Syros Pharmaceuticals and 56 more
Verified email available
Andrew SchiffVerified
Venture Capital, Private Equity Firm · United States
Health CareWomen FoundedLife ScienceBiotechnologyPortfolio: Zeltiq Aesthetics, Dermira, Spruce Biosciences, Syros Pharmaceuticals and 60 more
Verified email available
Eric AguiarVerified
Venture Capital, Private Equity Firm · United States
Health CareWomen FoundedLife ScienceBiotechnologyPortfolio: Zeltiq Aesthetics, Dermira, Spruce Biosciences, Syros Pharmaceuticals and 56 more
Verified email available
Josh BilenkerVerified
Venture Capital, Private Equity Firm · United States
Health CareWomen FoundedLife ScienceBiotechnologyPortfolio: Zeltiq Aesthetics, Dermira, Spruce Biosciences, Syros Pharmaceuticals and 56 more
Verified email available
Robert WenzelVerified
Venture Capital, Private Equity Firm · United States
Health CareWomen FoundedLife ScienceBiotechnologyPortfolio: Zeltiq Aesthetics, Dermira, Spruce Biosciences, Syros Pharmaceuticals and 56 more
Verified email available
Naveen Yalamanchi
Hedge Fund, Venture Capital, Investor · United States
Series BHealth CareGeneticsInvestment ManagementLife SciencePortfolio: AveXis, Frequency Therapeutics, Roivant Sciences, Magnolia Medical Technologies and 28 more
Contact details available
Piratip Pratumsuwan
Hedge Fund, Venture Capital, Investor · United States
Series BHealth CareGeneticsInvestment ManagementLife SciencePortfolio: AveXis, Frequency Therapeutics, Roivant Sciences, Magnolia Medical Technologies and 29 more
Contact details available
Roderick Wong
Hedge Fund, Venture Capital, Investor · United States
Series BHealth CareGeneticsInvestment ManagementLife SciencePortfolio: AveXis, Frequency Therapeutics, Roivant Sciences, Magnolia Medical Technologies and 29 more
Contact details available
Sabera Loughran
Hedge Fund, Venture Capital, Investor · United States
Series BHealth CareGeneticsInvestment ManagementLife SciencePortfolio: AveXis, Frequency Therapeutics, Roivant Sciences, Magnolia Medical Technologies and 28 more
Contact details available
Tony Nguyen
Hedge Fund, Venture Capital, Investor · United States
Series BAdvertisingHealth CareGeneticsInvestment ManagementPortfolio: AveXis, Frequency Therapeutics, Roivant Sciences, Magnolia Medical Technologies and 28 more
Contact details available
Norman Zhou
Venture Capital · United States
Health CareWomen FoundedLife ScienceInformation Technology (IT)Portfolio: Black Diamond Therapeutics, AveXis, Aligos Therapeutics, Tyra Biosciences and 46 more
Contact details available
Scott Braunstein
Venture Capital, Private Equity Firm · United States
Health CareWomen FoundedLife ScienceBiotechnologyPortfolio: Zeltiq Aesthetics, Dermira, Spruce Biosciences, Syros Pharmaceuticals and 56 more
Contact details available
Sophie Phillips
Private Equity Firm · United States
Health CareWomen FoundedLife ScienceBiotechnologyPortfolio: Zeltiq Aesthetics, Dermira, Spruce Biosciences, Syros Pharmaceuticals and 56 more
Contact details available
By investment stage
By location
Related industries
Most-backed portfolio companies
Frequently asked questions
How many Biomea Fusion investors are on Angel Roster?
Angel Roster lists 16 Biomea Fusion investors. 8 of them (50%) include a verified email address.
What types of investors are they?
The most common investor types are Venture Capital Firms (15), Private Equity Firms (8) and Hedge Funds (7). An investor can have more than one type, for example an angel who is also a venture partner.
Which stages do Biomea Fusion investors invest in?
Among those that list a stage, the most common are Series B (7) and Seed (1).
Where are Biomea Fusion investors based?
Most are based in the United States (16).
Which companies have Biomea Fusion investors backed?
The most-backed portfolio companies among them are Nuvation Bio (9), Atreca (9), Poseida Therapeutics (9), GTx (9) and Elevation Oncology (9).
How do I contact Biomea Fusion investors?
Create a free Angel Roster account to search and filter all 16, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.